article thumbnail

Bayer acquires Noria and PSMA Therapeutics to expand portfolio in prostate cancer

The Pharma Data

Noria was founded by Dr. John Babich, Chief, Radiopharmaceutical Sciences in Radiology at Weill Cornell Medicine. The companies acquired by Bayer, Noria and PSMA Therapeutics, have exclusive world-wide rights to technology licensed from Weill Cornell Medicine (New York, NY, USA) and Johns Hopkins University (Baltimore, MD, USA).

article thumbnail

Packaging Solutions for Pharmaceuticals & Medical Devices: Insights and Considerations

XTalks

Aaron Liss, Business Development at Curia, says that CCI testing (CCIT) is “essentially an elaborate term for leak testing performed in a very sensitive and quantitative fashion.” The FDA’s CDRH (Center for Devices and Radiological Health) branch would own the filing in this case.

article thumbnail

BioSpace Movers & Shakers, Nov. 20

The Pharma Data

Previously, she was head of Business Development at Cubist Pharmaceuticals. Hojvat served as the director of the Division of Microbiology Devices at the Center for Devices and Radiological Health at the Food and Drug Administration for 12 years. She has also held leadership positions at ViaCell and PerkinElmer.